Other

Pfizer in talks on $5 billion acquisition: media

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

Health

Nestle to trial plant-based eggs and shrimp

Nestle is offering plant-based alternatives to eggs and shrimp as the Swiss food giant expands its menu in the growing vegan market, the company said Thursday.

Medications

J&J and other drugmakers go on trial over US opioid crisis

Drugmakers including Johnson & Johnson on Tuesday denied claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed addiction risks, as the trial in a lawsuit filed ...

page 2 from 7